Avandia on the risk of heart attack and death from cardiovascular causes
Background Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined.
Attorney Consultation
Verdict
› $150,000,000 verdict in personal injury case